Literature DB >> 34236124

The gut brain in a dish: Murine primary enteric nervous system cell cultures.

Simone L Schonkeren1, Tara T Küthe1, Musa Idris1,2, Ana C Bon-Frauches1, Werend Boesmans1,3, Veerle Melotte1,2.   

Abstract

BACKGROUND: The enteric nervous system (ENS) is an extensive neural network embedded in the wall of the gastrointestinal tract that regulates digestive function and gastrointestinal homeostasis. The ENS consists of two main cell types; enteric neurons and enteric glial cells. In vitro techniques allow simplified investigation of ENS function, and different culture methods have been developed over the years helping to understand the role of ENS cells in health and disease.
PURPOSE: This review focuses on summarizing and comparing available culture protocols for the generation of primary ENS cells from adult mice, including dissection of intestinal segments, enzymatic digestions, surface coatings, and culture media. In addition, the potential of human ENS cultures is also discussed.
© 2021 The Authors. Neurogastroenterology & Motility published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adult mouse; enteric glial cells; enteric neurons; primary ENS culture; protocol

Mesh:

Year:  2021        PMID: 34236124      PMCID: PMC9285479          DOI: 10.1111/nmo.14215

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.960


INTRODUCTION

Many aspects of gastrointestinal physiology are under the control of the enteric nervous system (ENS), which is an extensive neural network embedded within the wall of the entire gastrointestinal tract and operates, to a large extent, independently from commands arriving from the central nervous system. Enteric neurons and enteric glial cells (EGCs) form the core of the ENS and are assembled into two interconnected ganglionated plexus layers. While the cell bodies of enteric neurons are mainly localized within the submucosal plexus (SMP), and between the circular and longitudinal muscle layers, within the myenteric plexus (MP), , , , , EGCs can also be found in the mucosa and muscle layers. Different enteric neuron subtypes can be classified according to their morphological, electrical, neurochemical, and molecular properties. , , EGC subtypes can be classified based on their morphology and location. , , Owing to its location close to the contractile gut musculature and intimate association with other intestinal cell types, such as epithelial, immune, and stromal cells, the development of adequate methodology to study the ENS has been a major challenge to the field. , , The generation of in vitro techniques has allowed the acquisition, expansion, and manipulation of ENS cells for a wide variety of research questions. They include (but are not limited to) primary ENS cell cultures in (semi‐)monolayer, stem cell‐derived 3D neurospheres, induced ENS cells from stem cell origin, and established cell lines. Initially, the investigation of the ENS using in vitro systems was established mostly in guinea pig gut, , , , , because of the extensive knowledge on anatomy, physiology, and chemical coding of guinea pig neurons. , However, the lack of genetically modified strains, as well as higher costs for housing and longer breeding times, made the ENS of mice the more commonly used exemplary. Primary ENS cells in early culture systems were extracted from neonatal tissue, , , but advancements in culture conditions, such as media and addition of growth factors have enabled the culture of adult primary ENS cells. To culture mature neuronal cells can still be challenging for different reasons: (1) they do not take part in cell division, so they can only be maintained for a limited amount of time; (2) the risk of overgrowth by other non‐ENS contaminants, for instance, fibroblasts and smooth muscle cells; (3) possible overgrowth of EGCs when the main interest is enteric neurons; and (4) risk of contamination by luminal contents containing bacteria and fungi. In this review, we summarize and compare currently available protocols for the isolation and culture of primary enteric neurons and EGCs obtained from the adult mouse intestine. We also discuss the methodology to generate human ENS cell cultures.

GENERATION OF MURINE PRIMARY ENS CULTURES

The generation of primary ENS cell cultures occurs in different steps. Below we discuss the different possibilities for isolation of the target tissue, the available approaches for the dissociation of the target cells, and possible culture maintenance techniques for murine primary ENS cultures. We will discuss culture methodology for ENS cultures focused on the isolation of neuronal cells (termed “ENS cultures”, as these cultures never consist of neurons solely) and for ENS cultures focused on the isolation of glial cells (termed “EGC cultures”, as they can be more purified).

Dissection and isolation

Depending on the research questions, different regions of the gut can be used (Figure 1A). In the small intestines of adult mice, for instance, the ENS meshwork is loosely arranged, with longer connecting nerve fiber strands resulting in a less compact structure.
FIGURE 1

Schematic representation of the steps involved in the dissection of tissue to isolate ENS cells. A Tissue dissection from the adult mouse, highlighting the different segments of the intestines. Isolated segments are cleaned and kept viable in BSS. B Two different isolation techniques for the LMMPs. Technique I involves the isolation of LMMPs from unopened segments and technique II includes opening intestinal segments and isolating the LMMP from the underlying mucosa and submucosa. C Rinsing of isolated tissue pieces by centrifugation in ice‐cold BSS and resuspension of the pellet. Abbreviations: BSS = basal salt solution; LMMP = longitudinal muscle myenteric plexus. Created with BioRender.com.

Schematic representation of the steps involved in the dissection of tissue to isolate ENS cells. A Tissue dissection from the adult mouse, highlighting the different segments of the intestines. Isolated segments are cleaned and kept viable in BSS. B Two different isolation techniques for the LMMPs. Technique I involves the isolation of LMMPs from unopened segments and technique II includes opening intestinal segments and isolating the LMMP from the underlying mucosa and submucosa. C Rinsing of isolated tissue pieces by centrifugation in ice‐cold BSS and resuspension of the pellet. Abbreviations: BSS = basal salt solution; LMMP = longitudinal muscle myenteric plexus. Created with BioRender.com. In the colon, however, specifically in the proximal colon, ENS organization is more compact and dense within the MP, making the separation of the muscle layer from the underlying submucosal layer rather difficult, as observed in rat. The organ of choice can be isolated from the animal by sterilizing and opening the abdominal wall, without injuring the underlying structures to expose the gastrointestinal tract, lifting the intestine with forceps, and cutting through the mesentery with scissors. After removing the intestine(s) from the animal, it is essential to keep the tissue viable by continuously maintaining adequate levels of ionic and osmotic balance. This can be achieved by placing it immediately in a balanced basal salt solution (BSS) supplemented with carbohydrates (Figure 1A). Different basal salt solutions have been used including Hank's balanced salt solution (HBSS), Krebs, , Krebs‐HBSS, Krebs‐Ringer solution, and DPBS, , generally containing the same essential constituents: calcium, magnesium, potassium, sodium, and phosphate. The function of BSS is fivefold: (I) the maintenance of intra‐ and extracellular osmotic balance during washing and dilution steps; (II) the preservation of intracellular water and ion concentrations essential for healthy cell physiology; (III) buffering the medium to maintain a physiological pH range; (IV) in case of supplementation with carbohydrates it provides a principle energy source; and (V) the provision of oxygen in case of bubbling with an O2/CO2 gas mixture. Depending on the type of cell culture, different plexus layers may be prioritized. For example, for ENS cultures, composed of both neurons and EGCs, longitudinal muscle containing the myenteric plexus (LMMP) preparations are commonly used as the MP accommodates a larger number of neurons than the SMP. , , , , However, it must be noted that SMP neurons and EGCs have different properties than MP neurons and EGCs. , , Cultures consisting solely of MP neurons might thus not adequately represent the properties of SMP neurons, which has to be taken into consideration. For cultures focused on the isolation of EGCs, the submucosa and mucosa, as well as the LMMP, have been used as tissue sources, , indicating that either tissue source can be used depending on the research question. Because the layers of the intestinal walls in rodents are very thin, soft, and delicate, the dissection and isolation of the ENS require careful tissue manipulation. Following the removal of debris and feces from the intestinal segments, the isolation of the plexus layers is usually performed by either of two techniques. Technique I includes cutting the intestine in small pieces and making a gentle incision along the line where the mesentery was attached after placing the segment on a small rod or syringe, followed by gentle stroking with a wetted cotton swap along the entire segment to peel away the LMMP (Figure 1B). Technique II involves longitudinal opening of the intestinal segment along the mesenteric line and then peeling off the LMMP (Figure 1B). In both techniques, it is crucial to cut along the mesenteric line, as the dissection of the MP is hindered here due to the presence of ducts and blood vessels. It should be noted that technique II requires more time than technique I, but allows for a more precise separation of the muscularis externa from the lamina propria mucosa. The majority of the reviewed protocols utilized isolation technique I , , , compared to technique II. , Some modifications have been made on both techniques. For instance, Wahba et al. described a technique involving stretching and pinning of the unopened segment on a Sylgard plate instead of placing it on a rod, followed by scraping off the LMMP from the entire length of the intestinal segment with curved forceps. In the protocol used by Verissimo et al. (2019) for EGC culture, technique II is adapted by only removing the mucosa to obtain ENS cells from the SMP and MP. Wang et al. (2018), focusing on the isolation of EGCs from the mucosa, submucosa, and circular muscle, used technique I to separate the LMMP, but discarded it and used the remaining tissue containing the SMP and lamina propria for further processing. Following the isolation of the plexus, dissociated cells are cleaned and separated from remaining debris by rinsing and centrifuging three to four times with BSS, a step shared by all analyzed protocols (Figure 1C).

Cell dissociation

The dissociation of ENS cells for culturing can be achieved mechanically and/or enzymatically. Mechanical dissociation involves either cutting, sieving, or triturating the isolated tissue and can be much faster than enzymatic digestion. It is suitable for large amounts of soft tissue, but can lead to tissue damage and lower yield of viable cells. Enzymatic digestion of cell‐cell adhesion components using proteases is the most common step for cell isolation from adjacent tissues. Proteases are distinctive in their molecular specificity, and different tissues therefore require different enzymatic activity depending on their matrix composition. In addition, DNase can be used to digest the DNA that is released due to the digestion of connective tissue and smooth muscle cells, as it can form long strings that tie up cells. The most common enzymes used in the protocols analyzed in this review were collagenases, trypsin, DNase, or a combination thereof (Table 1). Only the study by Wang et al. made use of non‐enzymatic digestion (EDTA), which is also the only study using the submucosa, mucosa, and circular muscle instead of the LMMP.
TABLE 1

Different enzymatic digestion conditions included in the reviewed protocols. Concentrations are shown as described in the protocols, temperatures are indicated in Celsius, incubation times are presented in minutes. Missing values indicated by (‐).

Protocol sourceEnzymeConcentrationSerial/combinatoryIncubation timeTemperature
Zhang and Hu. 2013 25

Collagenase IV

Trypsin

1 mg/ml

0.05%

Serial

15 min

10 min

37°C water bath shaker
Smith et al. 2013 27

Collagenase II

Trypsin

1.3 mg/ml

0.05%

Serial

60 min

7 min

37°C water bath shaker
Lowette et al. 2014 28

Collagenase

Protease

Albumin

14.67 mg/ml

10 mg/ml

5% in PBS

Combinatory8 min37°C
Wahba et al. 2016 29

Collagenase IV

Trypsin

1 mg/ml

0.05%

Serial

15 min

10–15 min

37°C water bath

manual rotation

Brun and Akbarali. 2018 26

Collagenase I

DNase I

0.5 mg/ml

0.5 mg/ml

Serial35 min37°C water bath shaker

Verissimo et al. 2019 31

EGCs

Collagenase II

DNase I

Combinatory60 min37°C

Wang et al. 2018 30

EGCs

Non‐enzymatic digestion
Different enzymatic digestion conditions included in the reviewed protocols. Concentrations are shown as described in the protocols, temperatures are indicated in Celsius, incubation times are presented in minutes. Missing values indicated by (‐). Collagenase IV Trypsin 1 mg/ml 0.05% 15 min 10 min Collagenase II Trypsin 1.3 mg/ml 0.05% 60 min 7 min Collagenase Protease Albumin 14.67 mg/ml 10 mg/ml 5% in PBS Collagenase IV Trypsin 1 mg/ml 0.05% 15 min 10–15 min 37°C water bath manual rotation Collagenase I DNase I 0.5 mg/ml 0.5 mg/ml Verissimo et al. 2019 EGCs Collagenase II DNase I Wang et al. 2018 EGCs Next to the choice of the particular enzyme(s) and their concentration, also the temperature and time of incubation are crucial determinants of successful enzymatic digestion. In order to allow the enzymes to reach their targets, the removal of fat tissue and unwanted muscle layers, and a sufficient level of mechanical dissociation prior to the digestion step greatly influence the efficacy of enzymatic dissociation of ENS cells. Together, these factors determine how well the tissue is dissociated and the subsequent cell viability. After dissociation, enzymes should be removed from the samples before seeding with gentle centrifugation steps to ensure that no further damage is exerted on the cells. One advantage of using enzymatic digestion for the isolation of ENS cells is the absence of collagen within the MP. The use of collagenase therefore allows almost complete digestion of surrounding muscle‐ and connective tissues while maintaining the structure of the ENS. , , However, over‐digestion, thus destroying the extracellular matrix (ECM) and endogenous structure completely, will lead to lower viable cell yield. Collagenase cleaves the peptide bonds between neutral amino acids and glycine, a sequence commonly found in collagen. Different types of collagenase exist, each recommended for different types of tissue. Collagenase exists in crude and highly purified form, whereas the crude collagenase mixtures usually contain a mixture of collagenase, and other enzymes with tryptic activity, enabling the digestion of other ECM components. Trypsin is a serine protease that cleaves peptide bonds at the C‐terminal end of positively charged side chains of lysine or arginine. It is innately found in the pancreas of most vertebrates and aids the cleavage of dietary proteins into peptides. Trypsin has the strongest relative digestive power and is one of the most specific proteases known, making it less effective for tissue dissociation due to its decreased selectivity for extracellular proteins. The tryptic activity has to be neutralized by either serum or trypsin inhibitors to reduce residual activity after washing. It is important to note that the use of trypsin can alter excitability of enteric neurons. , , Neither of the protocols included in this review used trypsin alone for cell dissociation. It is mostly combined with collagenase to increase the specificity for ECM proteins, allowing the breakup of enteric ganglia and release of individual neurons. Deoxyribonuclease I (DNase I) is an endonuclease that cleaves phosphodiester linkages in single‐ and double‐stranded DNA and has a less aggressive digestive capacity. It is often included in tissue dissociation mixtures to digest nucleic acids leaking into the dissociation medium, without damaging the intact cells in order to decrease viscosity and improve cell yield. Caution is warranted when combined with other proteases, such as trypsin, which proteolytic activity inactivates other enzymes. Therefore, DNase I and trypsin should not be added together, but serially after washing. Both serial and combinatory enzymatic digestion steps were used in the reviewed articles (Table 1), and the most common combination used was a type of collagenase together with trypsin, , , followed by a collagenase and DNase I. , All enzymatic digestion steps were performed at 37°C.

Culture maintenance

It is essential for neuronal survival in vitro to provide a to facilitate adhesion. , Prior investigations showed that ganglia in the adult (mammalian) MP are surrounded by an ECM arrangement of collagen IV, laminin, fibronectin, and proteoglycans. , It has been shown that poly‐D‐lysine coated coverslips can support the attachment of primary neurons and neural precursor cells, and specifically enteric neurons, when combined with fibronectin or laminin. All reviewed studies reported to coat coverslips or wells themselves, although commercially available coated coverslips and culture plates are currently readily available. The most used coating substrates for enteric neuronal cultures include Matrigel, laminin, poly‐D‐lysine, and poly‐L‐lysine. However, the choice for the adequate coating substrate for ENS and EGC cultures also greatly depends on experimental setup and purpose. Coating is especially beneficial for downstream microscopic analysis, as cells less likely adhere to glass, the preferred material for most microscopic analyses, than to culture‐treated plastics. Care must be taken to ensure that the chosen coating does not interfere with downstream analyses, such as second‐harmonic generation imaging of cells grown on a collagen‐containing matrix, like Matrigel. Poly‐D‐lysine and poly‐L‐lysine are chemically synthesized ECM molecules, and the most commonly used coating substrates to aid cell adhesion in pre‐treated tissue culture surfaces. The structure and molecular weight of Poly‐D‐lysine make it ideal for neuronal culture applications since this isoform is less readily digested by extracellular proteases. Laminin is a glycoprotein component of the basement membrane which modulates cellular functions including attachment, spread, growth, and mobility by binding to itself and other matrix components. Laminin is often used as a coating substrate in neuronal cultures since many neuronal cells express specific laminin‐binding proteins. It is also part of the basement membrane and ECM surrounding the ENS, as well as in the muscle layers of the adult mouse gut. In enteric neuronal development, laminin also stimulates neurite outgrowth. Fibronectin is an ECM glycoprotein produced by fibroblasts and is involved in cell migration and adhesion during ENS development. It is frequently used in vitro to enhance cell attachment and proliferation. Similar to laminin, fibronectin is part of the basement membrane in the MP. Matrigel is a commercially available soluble basement membrane extract containing predominantly laminin, fibronectin, and proteoglycans. Its adherent matrices simulate the cells’ ECM environment more closely due to the mixture of several matrix components, , as is found in ECM in vivo. The usage of Matrigel in neuronal culture models is predominantly optimal for neural stem‐ or progenitor cells, , where it has been proven to enhance survival and differentiation of neural crest cells from human and mouse. Zhang et al. 2013 also achieved the highest efficacy in attachment and growth of primary enteric neurons, and differentiating and neural stem/progenitor cells with Matrigel‐coated coverslips. Similarly, Wahba et al. 2015 reached the highest cell density with Matrigel‐collagen coatings, compared to other single and double coating substrates. The most commonly used double coatings are poly‐lysine and laminin, with poly‐D‐lysine being the prioritized isoform , , , over poly‐L‐lysine. Matrigel coatings were applied in two ENS cultures. , Coating substrates in EGC cultures included poly‐D‐lysine‐laminin and poly‐L‐lysine‐laminin. Furthermore, the success of a cell culture experiment is greatly influenced by the choice of the , and the constituent cell types largely determine which medium is required. Basal culture media dispense a source of energy, maintain beneficial ionic strength, pH concentration, and take up debris and metabolites from cultured cells. Essential components usually include inorganic salts, glucose or other carbohydrates, essential amino acids, vitamins (B complex), and phenol red as a pH indicator. Besides these essential components, antibiotics and antimycotics are included to prevent microbial contamination. Despite the availability of specialized neuronal media (Neurobasal‐A, Gibco), standard DMEM medium supplemented with the F12 nutrient mix (Gibco) , , , , and cell type‐specific supplements are most frequently used in murine primary ENS cultures. The addition of serum to the basal culture media is used to provide signals for survival, growth, and differentiation. Generally fetal bovine serum (FBS), , , , , , in concentrations ranging from 1 to 10%, was used for ENS cultures. Only one protocol uses chick embryo extract (CEE) instead of FBS. FBS is the most widely used form of serum due to low contents of complement factors and immunoglobulins. However, serum‐free media and supplements allow culturing of neurons at low density, which enables the study of individual neurons and their projections. Next to serum, certain growth factors, for example, nerve growth factor (NGF) and glial cell line‐derived neurotrophic factor (GDNF), and hormones are often added as well. These can be supplied individually or as part of commercially available supplement mixtures such as B27, N2, and G5. Despite the supplements, no major differences have been observed between the use of media for ENS cultures compared to EGC cultures. Table 2 gives a detailed overview of the culture protocols used in the reviewed studies, including culture type, isolation techniques, enzymatic digestion, coating substrates, and culture media.
TABLE 2

Comparison of murine adult ENS primary culture protocols, with a detailed overview of mouse strains, age, dissection techniques, dissociation methods, coating agents, and culture medium specifications. Abbreviations: HBSS = Hank's balanced salt solution; FBS = fetal bovine serum.

SourceCulture typeMouse strain and ageDissection technique, intestine segment, and BSSCell dissociationCoating substrates and platingMedium and maintenance

Lowette et al. 2014 28

ENS culture

Adult

C57BL/N6 Mouse

(8–9 weeks)

Technique I

Ileum

Krebs‐HBSS

Digestion solution: Collagenase (14.67 mg/ml), protease (10 mg/ml), albumin (5% in PBS).

Incubation time: 8 min at 37°C.

Stopped with Krebs, 10% FBS at RT.

Poly‐D‐lysine‐laminin double coating:

Poly‐D‐lysine hydrobromide (0.5 mg/ml in borate buffer).

Laminin (20 µg/ml).

Complete medium: DMEM‐F12 (1:1), 10% FBS, 1% glutamine, 0.5% pen/strep.

Serum‐free medium: DMEM‐F12, with NGF (0.05%), N2 (0.2%), G5 (0.2%).

Medium replaced by serum‐free medium after 24h.

Zhang and Hu. 2013 25

ENS culture

Adult Mouse

Technique II

Complete small intestine

HBSS

Collagenase digestion medium: 1 mg/ml collagenase IV, 0.5 mM CaCl2, 10 mM HEPES in HBSS.

Trypsin Digestion medium: 0.05% trypsin with 0.53 mM EDTA in HBSS.

Digestion neutralizing medium: 500 U DNase I, 1 mg/ml BSA in DMEM/F12 medium.

Matrigel coating:

BD GF‐reduced Matrigel: 60% laminin, 30% collagen IV, 8% entactin, diluted 1:2000 in ice‐cold DMEM/F12 medium.

Density of seeding: 1 × 105/cm2; with enteric neuronal culture medium.

Enteric neuronal culture medium: DMEM/F12 medium (39.5 ml), chick embryo extract (7.5 ml), penicillin/streptomycin (100×, 0.5 ml), gentamicin (500×, 100 µl), amphotericin (100×, 0.5 ml), N2 (100×, 0.5 ml), B27 (50×, 1 ml), glutamine (100× 0.5 ml), FGF‐b (10 µg/ml, 50 µl), EGF (10 µg/ml, 100 µl), heparin (0.2%, 5 µl).

Medium change every day.

Smith et al. 2013 27 ENS cultureAdult Mouse

Technique I

Ileum

Krebs solution

Collagen digestion solution: 13 mg collagenase type II, 3 mg BSA in 10 ml carbogen‐bubbled Krebs.

Incubation time: 60 min at 37°C.

Trypsin digestion solution (0.05% trypsin): 5 ml of 0.05% trypsin solution.

Incubation time: 7 min at 37°C in shaking water bath.

Rinse medium: F12 medium with 10% FBS and antibiotic/antimycotic: to 500 ml bottle F12 media add 50 ml FBS and 5 ml antibiotic/antimycotic 100× liquid.

Poly‐D‐lysine‐laminin double coating:

1 ml/25cm2 poly‐D‐lysine: 80 µl poly‐D‐lysine stock/CS.

5 µg/cm2 laminin: 200 µl stock/CS.

Neuronal culture medium: Neurobasal‐A medium, B27, 2 mM L‐glutamine, 1% FBS, 10 ng/ml GDNF and antibiotic/antimycotic 100× liquid.

Change half of medium every 2 days.

Wahba et al. 2016 29

ENS culture

CD−1 mouse (4–6 month)

Technique Ib

Complete small intestines

Krebs‐Ringer Solution

Collagenase digestion solution: 1 ml per mouse: 1 mg/ml collagenase IV, 0.5 mM CaCl2, 10 mM HPES in HBSS.

Incubation time: 15 min at 37°C in water bath with manual constant rotation once every 5 min.

Trypsin digestion solution: 0.05% trypsin, 0.54 mM EDTA in HBSS, 1 ml/mouse.

Incubation time: 10 min in 37°C water bath with manual rotation and inverting of tube every 5 min once.

5 different culture substrates tested:

Poly‐D‐lysine (0.1 mg/ml, 50 µl, overnight at RT),

Collagen (100 µg/ml, 50 µl, overnight at RT);

Matrigel (MG) (1.8 mg/ml, 100 µl: 15 µl of MG in 85 µl culture media, 2h at 37°C);

Poly‐D‐lysine /MG mix (Poly‐D‐lysine: 0.03 mg/ml 50 µl; MG: 0.5 mg/ml 15 µl in 85 µl media mix, 2h at 37°C);

Collagen/MG mix: Collagen: 50 µl of 33µg/ml; MG: 0.5 mg/ml, 15 µl in 85 µl culture medium, 2h at 37°C).

Wash once with pre‐warmed (37°C) HBSS.

Complete medium: DMEM/F12, 2% (v/v) FBS, 100 U/ml pen, 100 µg/ml strep, 1 × B27, N2, 7.2 mg/L uridine triphosphate, 50 mg/L gentamycin.

Medium change every day.

Brun and Akbarali. 2018 26

ENS cultureAdult C57BL/6 J mice

Technique I

Ileum

Krebs solution

Neuronal digestion solution: 13 mg collagenase type II + 3 mg BSA in 10 ml RMPI medium 1640.

Incubation time: 15 min at 37°C in water bath under shaking conditions.

0.05% Trypsin solution: 1 ml warmed 0.25% trypsin in 4 ml warmed RPMI medium 1640.

Incubation time: 7 min at 37°C water bath shaking.

Digestion stopped with Krebs solution.

Poly‐D‐lysine‐laminin double coating:

Dilute poly‐D‐lysine stock (0.01% in ddH2O) and take 150 µl stock/cm2.

Incubate at RT for 30 min.

Dilute laminin stock to 5 µg/ml with ddH2O, take 100 µl of laminin solution/cm2.

Incubate at RT for 1h.

Complete neuron medium: Neurobasal‐A medium/B27, 1 × L‐glutamine (2 mM), Pen/strep (100 U/ml and 100 µg/ml), sodium pyruvate (1 mM), 1%FBS, 10 ng/ml human recombinant GDNF.

150 µl of cell suspension in 1 ml complete medium.

Medium change every 2 days.

For electrophysiological studies: add 850 µl of cell/cm2 to the coated CS.

Verissimo et al. 2019 31 EGC cultureAdult mouse

Technique II

Complete colon

PBS with Pen/strep and fungizone

Enzymatic dissociation: Collagenase II (Gibco), DNase I (Sigma chemical).

60 min at 37°C.

Mechanical dissociation and centrifugation 2×.

Poly‐L‐lysine‐laminin and Fibronectin single coating:

Poly‐L‐lysine‐laminin substrate: 50 µg/ml in acid buffer (20 mM sodium acetate in 2 mM Calcium chloride), incubated with CS at least 12h at 37°C, 3× wash with PBS.

Fibronectin substrate: 50 µg/ml in DMEM/F12, incubated with CS for 1h at 37°C, removed from wells and dried.

Re‐plated after 3 days in culture to distribute cells homogenously.

Medium: DMEM/F12, 2 mM glutamine, 3 mM sodium bicarbonate (NaHCO3), 0.5 mg/ml pen/step, 10%FBS, 2% chick embryo extract.
Wang et al. 2018 30 EGC culture

Adult C57BL/6 mice

(8 weeks)

Technique I, but isolation of mucosa, submucosa, and circular muscle

Proximal small intestines

DPBS w/o Ca2+ or Mg2+

Non‐enzymatic digestion:

Sequential HEPES‐buffered EDTA incubations and gentle trituration.

Isolation solution: EDTA/HEPES/DPBS dissociation solution (500 ml): sterile DPBS (w/o Ca2+ and Mg2+) to make final solution of 10 mM HEPES and 5 mM EDTA.

Use 490 ml DPBS, 5 ml 1 m HEPES buffer, 5 ml 0.5 m EDTA stock.

Cell recovery solution: commercially available.

Poly‐D‐lysine ‐laminin double coating:

1 mg/ml poly‐D‐lysine stock diluted 1:10 in sterile tissue culture grade water.

Final concentration: 100 µg/ml; 2 ml per well in 6‐well plates;

Incubate 1 h.

Dilute laminin (0.5 mg/ml stock) 1:50 in DPBS.

final concentration: 10 µg/ml; 1 ml per 6‐well plate.

Incubate 2h at 37°C, then remove laminin wash gently 3× with sterile DPBS.

Glia cell resuspension media: 44.5 ml DMEM/F12, 5 ml FBS (10%), 500 µl Pen/Strep (100 U/ml Pen, 100 µg/ml Strep), 20 µl Gentamicin (20 µg/ml).

Glial cell growth medium:

44 ml DMEM/F12, 5 ml FBS (10%), 500 µl Pen/strep (100 U/ml pen, 100 µg/ml strep), 20 µl Gentamicin (20 µg/ml), 50 µl GDNF (10 ng/ml), 500 µl L‐glutamine (2 mM).

200 µl cell suspension onto each CS.

Complete medium change every day.

Comparison of murine adult ENS primary culture protocols, with a detailed overview of mouse strains, age, dissection techniques, dissociation methods, coating agents, and culture medium specifications. Abbreviations: HBSS = Hank's balanced salt solution; FBS = fetal bovine serum. Lowette et al. 2014 Adult C57BL/N6 Mouse (8–9 weeks) Technique I Ileum Krebs‐HBSS Digestion solution: Collagenase (14.67 mg/ml), protease (10 mg/ml), albumin (5% in PBS). Incubation time: 8 min at 37°C. Stopped with Krebs, 10% FBS at RT. Poly‐D‐lysine‐laminin double coating: Poly‐D‐lysine hydrobromide (0.5 mg/ml in borate buffer). Laminin (20 µg/ml). Complete medium: DMEM‐F12 (1:1), 10% FBS, 1% glutamine, 0.5% pen/strep. Serum‐free medium: DMEM‐F12, with NGF (0.05%), N2 (0.2%), G5 (0.2%). Medium replaced by serum‐free medium after 24h. ENS culture Technique II Complete small intestine HBSS Collagenase digestion medium: 1 mg/ml collagenase IV, 0.5 mM CaCl2, 10 mM HEPES in HBSS. Trypsin Digestion medium: 0.05% trypsin with 0.53 mM EDTA in HBSS. Digestion neutralizing medium: 500 U DNase I, 1 mg/ml BSA in DMEM/F12 medium. Matrigel coating: BD GF‐reduced Matrigel: 60% laminin, 30% collagen IV, 8% entactin, diluted 1:2000 in ice‐cold DMEM/F12 medium. Density of seeding: 1 × 105/cm2; with enteric neuronal culture medium. Enteric neuronal culture medium: DMEM/F12 medium (39.5 ml), chick embryo extract (7.5 ml), penicillin/streptomycin (100×, 0.5 ml), gentamicin (500×, 100 µl), amphotericin (100×, 0.5 ml), N2 (100×, 0.5 ml), B27 (50×, 1 ml), glutamine (100× 0.5 ml), FGF‐b (10 µg/ml, 50 µl), EGF (10 µg/ml, 100 µl), heparin (0.2%, 5 µl). Medium change every day. Technique I Ileum Krebs solution Collagen digestion solution: 13 mg collagenase type II, 3 mg BSA in 10 ml carbogen‐bubbled Krebs. Incubation time: 60 min at 37°C. Trypsin digestion solution (0.05% trypsin): 5 ml of 0.05% trypsin solution. Incubation time: 7 min at 37°C in shaking water bath. Rinse medium: F12 medium with 10% FBS and antibiotic/antimycotic: to 500 ml bottle F12 media add 50 ml FBS and 5 ml antibiotic/antimycotic 100× liquid. Poly‐D‐lysine‐laminin double coating: 1 ml/25cm2 poly‐D‐lysine: 80 µl poly‐D‐lysine stock/CS. 5 µg/cm2 laminin: 200 µl stock/CS. Neuronal culture medium: Neurobasal‐A medium, B27, 2 mM L‐glutamine, 1% FBS, 10 ng/ml GDNF and antibiotic/antimycotic 100× liquid. Change half of medium every 2 days. Wahba et al. 2016 CD−1 mouse (4–6 month) Technique Ib Complete small intestines Krebs‐Ringer Solution Collagenase digestion solution: 1 ml per mouse: 1 mg/ml collagenase IV, 0.5 mM CaCl2, 10 mM HPES in HBSS. Incubation time: 15 min at 37°C in water bath with manual constant rotation once every 5 min. Trypsin digestion solution: 0.05% trypsin, 0.54 mM EDTA in HBSS, 1 ml/mouse. Incubation time: 10 min in 37°C water bath with manual rotation and inverting of tube every 5 min once. 5 different culture substrates tested: Poly‐D‐lysine (0.1 mg/ml, 50 µl, overnight at RT), Collagen (100 µg/ml, 50 µl, overnight at RT); Matrigel (MG) (1.8 mg/ml, 100 µl: 15 µl of MG in 85 µl culture media, 2h at 37°C); Poly‐D‐lysine /MG mix (Poly‐D‐lysine: 0.03 mg/ml 50 µl; MG: 0.5 mg/ml 15 µl in 85 µl media mix, 2h at 37°C); Collagen/MG mix: Collagen: 50 µl of 33µg/ml; MG: 0.5 mg/ml, 15 µl in 85 µl culture medium, 2h at 37°C). Wash once with pre‐warmed (37°C) HBSS. Complete medium: DMEM/F12, 2% (v/v) FBS, 100 U/ml pen, 100 µg/ml strep, 1 × B27, N2, 7.2 mg/L uridine triphosphate, 50 mg/L gentamycin. Medium change every day. Brun and Akbarali. 2018 Technique I Ileum Krebs solution Neuronal digestion solution: 13 mg collagenase type II + 3 mg BSA in 10 ml RMPI medium 1640. Incubation time: 15 min at 37°C in water bath under shaking conditions. 0.05% Trypsin solution: 1 ml warmed 0.25% trypsin in 4 ml warmed RPMI medium 1640. Incubation time: 7 min at 37°C water bath shaking. Digestion stopped with Krebs solution. Poly‐D‐lysine‐laminin double coating: Dilute poly‐D‐lysine stock (0.01% in ddH2O) and take 150 µl stock/cm2. Incubate at RT for 30 min. Dilute laminin stock to 5 µg/ml with ddH2O, take 100 µl of laminin solution/cm2. Incubate at RT for 1h. Complete neuron medium: Neurobasal‐A medium/B27, 1 × L‐glutamine (2 mM), Pen/strep (100 U/ml and 100 µg/ml), sodium pyruvate (1 mM), 1%FBS, 10 ng/ml human recombinant GDNF. 150 µl of cell suspension in 1 ml complete medium. Medium change every 2 days. For electrophysiological studies: add 850 µl of cell/cm2 to the coated CS. Technique II Complete colon PBS with Pen/strep and fungizone Enzymatic dissociation: Collagenase II (Gibco), DNase I (Sigma chemical). 60 min at 37°C. Mechanical dissociation and centrifugation 2×. Poly‐L‐lysine‐laminin and Fibronectin single coating: Poly‐L‐lysine‐laminin substrate: 50 µg/ml in acid buffer (20 mM sodium acetate in 2 mM Calcium chloride), incubated with CS at least 12h at 37°C, 3× wash with PBS. Fibronectin substrate: 50 µg/ml in DMEM/F12, incubated with CS for 1h at 37°C, removed from wells and dried. Re‐plated after 3 days in culture to distribute cells homogenously. Adult C57BL/6 mice (8 weeks) Technique I, but isolation of mucosa, submucosa, and circular muscle Proximal small intestines DPBS w/o Ca2+ or Mg2+ Non‐enzymatic digestion: Sequential HEPES‐buffered EDTA incubations and gentle trituration. Isolation solution: EDTA/HEPES/DPBS dissociation solution (500 ml): sterile DPBS (w/o Ca2+ and Mg2+) to make final solution of 10 mM HEPES and 5 mM EDTA. Use 490 ml DPBS, 5 ml 1 m HEPES buffer, 5 ml 0.5 m EDTA stock. Cell recovery solution: commercially available. Poly‐D‐lysine ‐laminin double coating: 1 mg/ml poly‐D‐lysine stock diluted 1:10 in sterile tissue culture grade water. Final concentration: 100 µg/ml; 2 ml per well in 6‐well plates; Incubate 1 h. Dilute laminin (0.5 mg/ml stock) 1:50 in DPBS. final concentration: 10 µg/ml; 1 ml per 6‐well plate. Incubate 2h at 37°C, then remove laminin wash gently 3× with sterile DPBS. Glia cell resuspension media: 44.5 ml DMEM/F12, 5 ml FBS (10%), 500 µl Pen/Strep (100 U/ml Pen, 100 µg/ml Strep), 20 µl Gentamicin (20 µg/ml). Glial cell growth medium: 44 ml DMEM/F12, 5 ml FBS (10%), 500 µl Pen/strep (100 U/ml pen, 100 µg/ml strep), 20 µl Gentamicin (20 µg/ml), 50 µl GDNF (10 ng/ml), 500 µl L‐glutamine (2 mM). 200 µl cell suspension onto each CS. Complete medium change every day.

Cell density, viability, and functionality

Although the protocols show similarities in the different steps of establishing culture systems (Table 2), the lack of representative outcome parameters regarding viability, functionality, and the presence of subtypes represents a significant limitation in our comparison.

ENS cultures

Zhang and Hu (2013) proposed a standardized protocol for the isolation of primary ENS cells, with the extension of generating neurospheres starting from the same protocol. Briefly, the intestines of 8 week‐old mice were isolated by technique II described above (Figure 1B), and enzymatic digestion was performed with collagenase, followed by trypsin. After 1–2 days in culture, the cells attached to the substrate and developed longer processes. Morphological changes could be observed daily, and the attempts to form plexuses over a layer of glial cells, resembling ganglionic structures, were seen after 5–7 days in vitro. Staining with the neuronal marker βIII tubulin validated the presence of enteric neurons in these cultures. However, no data on the density, count, or functionality of cultured cells were shown in this study, nor in other studies using the same protocol. , Brun and Akbarali (2018) developed a protocol for the isolation of ENS cultures from the ileum of adult mice, providing two variations depending on the subsequent use of the cell culture: (1) a gentler digestion method involving only collagenase II is proposed for suspension cultures, which were used to assess the phenotype of neurons after stimulation; (2) extensive digestion for electrophysiological studies, involving serial treatment with collagenase II and trypsin. However, no results regarding cell viability, density, count, and functionality were reported for this protocol. , The protocols by Smith et al. and Wahba et al. both assessed functionality of the cultured ENS cells by calcium imaging after one week in vitro, confirming functionally viable cells in culture, identifying two electrophysiological distinct neuronal subtypes with a current clamp; synaptic (S‐) and after‐hyperpolarization (AH‐)neurons. Both protocols are based on dissection technique I and performed serial digestion with collagenase and trypsin, while Wahba et al. used DMEM/F12 and Smith et al used Neurobasal‐A medium supplemented with B27. Moreover, Wahba et al. tested a variety of coating substrates (Table 2). Immunofluorescence staining after 5–7 days in culture for DAPI, βIII tubulin, neuronal subtype markers, and the glial cell marker GFAP confirmed the presence of distinctive neurochemical subtypes (nNOS, VIP, and ChAT) in culture established by Wahba et al., and the presence of EGCs and enteric neurons in both studies. In the study by Wahba et al., the cellular density was found to be the highest when using collagen‐Matrigel double coatings, whereas Smith et al. kept the cell density low to avoid contamination, reaching 10%–40% confluence after one day in culture with Poly‐D‐lysine‐aminin coatings. The cell culture approach developed by Smith et al. has been adopted in several other studies, investigating viability, and functionality of enteric neurons in response to fungal extracts and morphine, as well as in studies using optogenetics analysis. Furthermore, the same protocol has been used to study EGCs, to generate other protocols for EGC cultures and was used together with intestinal stem cells and epithelial cells in co‐culture models. The protocol for primary ENS cultures used by Lowette et al. (2014) to investigate the role of corticosterone in the ENS, was similar to the study from Smith et al. in most steps, except for the enzymatic digestion, in which a combinatory digestion mixture of collagenase and proteases was used (Table 1). However, no data regarding viability, heterogeneity, or density of ENS cells in culture was described and can therefore not be compared.

EGC cultures

The protocols for EGCs cultures showed similarities by using DMEM/F12 culture media and serial enzymatic digestion with collagenase and DNase. The protocol by Wang et al. (2018), however, applies an entirely different approach by isolating the EGCs from the submucosa and lamina propria, instead of extracting them from the LMMP, followed by enzyme‐free digestion using EDTA incubation. Flow cytometry confirmed the presence of more than 95% EGCs after three days in culture. Yields of about 40,000–100,000 cells morphologically consistent with EGCs in vivo were confirmed after 1–3 days in culture on poly‐D‐lysine‐laminin substrate and expressed the main glial cell markers such as S100β, GFAP, and Sox10. Verissimo et al. (2019) established a protocol for the isolation of primary EGCs from both the SMP and MP to investigate the effects of laminin and environmental cues on the differentiation of EGCs into neurons. Immunofluorescence staining for glial‐ (GFAP and Sox10) and neuron‐specific markers (βIII‐tubulin) was employed to investigate the proportions of cells expressing one or both markers. The authors showed increased numbers of cells expressing both glial markers on the control substrate fibronectin and decreasing numbers of cells expressing both glial and neuronal markers on laminin substrate after seven days in vitro. Cell viability and activity were not assessed, and cultures were maintained for 21 days. Although comparing the ENS culture protocols in terms of outcomes remains challenging, murine primary ENS cultures have been used for many different research applications (a non‐exhaustive list of experimental methods used in ENS cultures is shown in Table 3).
TABLE 3

Key applications of murine ENS cultures.

ENS culture typeApplication
ENS culturePhenotypic assessment (immunofluorescence) 25 , 26 , 27 , 29 , 61 , 62 , 63 , 64 , 65 , 66 , 69
Assessment of gene expression (RNA) 63
Assessment of protein levels/alterations 61
Cytokine measurements 69
Cytotoxicity 62
Viability 65
Activity (electrophysiology) 26 , 27 , 66 , 67
Activity (calcium imaging) 28 , 65 , 67
Optogenetics 67
Co‐culture 69
EGC culturePhenotypic assessment (immunofluorescence) 30 , 31 , 68 , 112
Assessment of gene expression (RNA) 31
Assessment of protein levels 68
Cytotoxicity 112
Viability 112
Activity (calcium imaging) 30
Key applications of murine ENS cultures.

GENERATION OF HUMAN ENS CULTURES

All protocols for the isolation and culture of human primary ENS cells to date focus on the isolation of EGCs , , , (Table 4). Cells are generally isolated from the MP of small intestine, , , , , but SMP and also colon have been used as well. , Technique II is used for tissue dissection , , , , , as the size of the tissue renders the use of technique I inadequate. The human ENS is bigger and more complex, therefore, requiring longer digestion times for cell dissociation, which has been tested in direct comparison with murine and rat ENS. Most protocols use a combination of protease and collagenase , , , for tissue dissociation, while Grubišić et al. have successfully used a serial digestion with liberase (a blend of collagenase and protease) and DNase. The primary human EGCs are either grown in a culture dish without coating, , , or on glass slides coated with gelatin, or double coated with laminin and poly‐D‐lysine. In all protocols, the human EGCs are maintained on DMEM‐F12 medium with 10% fetal calf serum (FCS) , , or FBS , and antibiotic/antimycotic, without additional (glia‐specific) supplements. Instead, for purifying the culture of human primary EGC, magnetic beads linked to specific targets, such as Thy‐1.1 , or D7‐Fib , are often used to eliminate fibroblasts from the culture. With this method, Liñán‐Rico et al. and Grubišić et al. reached a cell enrichment of 10,000–20,000 fold. Soret et al. took a different approach and switched the medium after 48h to a DMEM‐based medium (not DMEM‐F12) without an additional purification step. They report a purity of around 80% EGCs and 20% other cell types, determined by immunohistochemistry.
TABLE 4

Comparison of human adult ENS primary culture protocols, with a detailed overview of donor material, dissection techniques, dissociation methods, coating agents, and culture medium specifications. Abbreviations: FCS = fetal calf serum; BSA = bovine serum albumin; HBSS = Hank's balanced salt solution; FBS = fetal bovine serum.

SourceCulture typeDonorsDissection technique, intestine segment, and BSSCell dissociationCoating substrates and platingMedium and maintenance
Cirillo et al. 2011 72 and Turco et al. 2014 71 EGC cultureColorectal cancer patients

Technique II

Small intestine

Krebs

Digestion solution: Protease (1 mg/ml), collagenase (1.25 mg/ml).

Incubation time: 30 min at 37°C.

No coating.

Medium: DMEM‐F12, 10% heat‐inactivated FCS, 1% antibiotic‐antimycotic solution.

Grow for 3–4 weeks and use Thy−1.1 antibody‐coated magnetic beads while passaging to eliminate fibroblasts and smooth muscle cells. Perform purification twice.

Soret et al. 2013 74 EGC culturePatients with colorectal cancer, polyps, Hirschprung, fistula, sigmoiditis, volvulus, or pancreatic adenoma

Technique II

Jejunum, ileum, colon (normal segments of resection margin)

Krebs

Digestion solution: 250 µl protease (type I from bovine pancreas; stock solution: 5 g/l), 250 µl collagenase (Clostridium histolyticum; stock solution:20 g/L), and 400 µl BSA (stock solution: 50 g/L) in 5 ml of complete medium.

Dissociated in a GentelMACS dissociator procedure A−01: 25s at cycles of 400 rpm clockwise and 300 rpm counter clockwise, once before and once after incubation in digestion solution.

Incubation time: 45 min at 37°C on a rocker.

Gelatin coating:

gelatin type A from Porcine skin 90–110; 0.5% in PBS.

Complete medium: DMEM/F12 supplemented with 10% heat‐inactivated FCS, 100 IU/ml penicillin, 100 µg/ml streptomycin, 1.1 µg/ml amphotericin B, 20 µg/ml gentamicin, 6 mM glutamine, 2.1 g/l NaHCO3.

After 48h half the medium is replaced with complete DMEM medium: DMEM 4.5 g/L glucose, 10% FCS, 2 mM glutamine, 50 IU/ml penicillin, 50 µg/ml streptomycin.

Liñán‐Rico et al. 2016 73 EGC culturePatients with polyps undergoing colectomy or patients undergoing Roux‐en‐Y‐ bypass surgery

Technique II

Sigmoid colon or jejunum

Krebs

Digestion solution: Protease (1 mg/ml), collagenase (1 mg/ml) in HBSS.

Incubation time: 60 min at 37°C.

Spin down and resuspend in HBSS (once) and then in DMEM‐F12 0.1% BSA and DNase (50 µg/ml). Collect ganglia with micropipette.

Laminin/Poly‐D‐Lysine coating:

20 mg/ml on 50 mm bottom glass #0 culture dishes.

Medium: DMEM‐F12 (1:1), 10% FBS, penicillin (100 U/ml), streptomycin (100 µg/ml), amphotericin B (0.25 µg/ml).

Grow for 3–4 weeks and use magnetic microbeads linked to D7‐Fib while passaging to eliminate fibroblasts. Perform purification twice.

Grubišić et al. 2020 70 EGC culturePatients with Crohn's disease

Technique II

Ileum

Krebs

Digestion solution: Liberase (0.125 mg/ml), Amphotericin B (0.5µg/ml) in DMEM‐F12.

Incubation time: 60 min at 37°C.

Spin down and resuspend in DMEM‐F12 0.1% BSA and DNase (50 µg/ml). Collect ganglia with micropipette.

No coating.

Medium: DMEM‐F12 (1:1), 10% FBS, penicillin (100 U/ml), streptomycin (100 µg/ml), amphotericin B (0.25 µg/ml).

Grow for 3–4 weeks and use magnetic microbeads linked to D7‐Fib while passaging to eliminate fibroblasts. Perform purification twice.

Comparison of human adult ENS primary culture protocols, with a detailed overview of donor material, dissection techniques, dissociation methods, coating agents, and culture medium specifications. Abbreviations: FCS = fetal calf serum; BSA = bovine serum albumin; HBSS = Hank's balanced salt solution; FBS = fetal bovine serum. Technique II Small intestine Krebs Digestion solution: Protease (1 mg/ml), collagenase (1.25 mg/ml). Incubation time: 30 min at 37°C. Medium: DMEM‐F12, 10% heat‐inactivated FCS, 1% antibiotic‐antimycotic solution. Grow for 3–4 weeks and use Thy−1.1 antibody‐coated magnetic beads while passaging to eliminate fibroblasts and smooth muscle cells. Perform purification twice. Technique II Jejunum, ileum, colon (normal segments of resection margin) Krebs Digestion solution: 250 µl protease (type I from bovine pancreas; stock solution: 5 g/l), 250 µl collagenase (Clostridium histolyticum; stock solution:20 g/L), and 400 µl BSA (stock solution: 50 g/L) in 5 ml of complete medium. Dissociated in a GentelMACS dissociator procedure A−01: 25s at cycles of 400 rpm clockwise and 300 rpm counter clockwise, once before and once after incubation in digestion solution. Incubation time: 45 min at 37°C on a rocker. Gelatin coating: gelatin type A from Porcine skin 90–110; 0.5% in PBS. Complete medium: DMEM/F12 supplemented with 10% heat‐inactivated FCS, 100 IU/ml penicillin, 100 µg/ml streptomycin, 1.1 µg/ml amphotericin B, 20 µg/ml gentamicin, 6 mM glutamine, 2.1 g/l NaHCO3. After 48h half the medium is replaced with complete DMEM medium: DMEM 4.5 g/L glucose, 10% FCS, 2 mM glutamine, 50 IU/ml penicillin, 50 µg/ml streptomycin. Technique II Sigmoid colon or jejunum Krebs Digestion solution: Protease (1 mg/ml), collagenase (1 mg/ml) in HBSS. Incubation time: 60 min at 37°C. Spin down and resuspend in HBSS (once) and then in DMEM‐F12 0.1% BSA and DNase (50 µg/ml). Collect ganglia with micropipette. Laminin/Poly‐D‐Lysine coating: 20 mg/ml on 50 mm bottom glass #0 culture dishes. Medium: DMEM‐F12 (1:1), 10% FBS, penicillin (100 U/ml), streptomycin (100 µg/ml), amphotericin B (0.25 µg/ml). Grow for 3–4 weeks and use magnetic microbeads linked to D7‐Fib while passaging to eliminate fibroblasts. Perform purification twice. Technique II Ileum Krebs Digestion solution: Liberase (0.125 mg/ml), Amphotericin B (0.5µg/ml) in DMEM‐F12. Incubation time: 60 min at 37°C. Spin down and resuspend in DMEM‐F12 0.1% BSA and DNase (50 µg/ml). Collect ganglia with micropipette. Medium: DMEM‐F12 (1:1), 10% FBS, penicillin (100 U/ml), streptomycin (100 µg/ml), amphotericin B (0.25 µg/ml). Grow for 3–4 weeks and use magnetic microbeads linked to D7‐Fib while passaging to eliminate fibroblasts. Perform purification twice. In addition to direct isolation of ENS cells from human tissue, methods have been developed to differentiate human pluripotent stem cells into ENS cells. These cells are self‐renewing and can be used for many applications. Several protocols have been established to generate neural crest‐derived cells from pluripotent stem cells , , , , , , , and further differentiate them to produce enteric neural lineages. , , , Generally, neural crest cell differentiation protocols depend on the manipulation of the BMP, WNT, FGF, NOTCH, TGFβ, and EGF pathways. In 2009, Chambers et al. formulated dual SMAD inhibition in pluripotent stem cells to produce neural crest cells in 11 days. This protocol has since been further optimized by the addition of the WNT activator CHIR99021 to the differentiation recipe, enhancing the efficiency of differentiation to neural crest cells. , Later, Fattahi et al. used retinoic acid (RA) between days 6 and 11 to promote the vagal fate of the neural crest cells which then expressed HOXB2‐B5, PAX3, EDNRB, and RET. After an intermediate step of suspension culture for 4 days in FGF2 and CHIR99021, further differentiating vagal neural crest cells using ascorbic acid and GDNF yielded TuJ+ neurons expressing a spectrum of markers including 5‐HT, GABA, and nNOS. The presence of glial cells in these cultures was not reported. In 2019, Barber et al. optimized the differentiation protocol further by replacing the undefined serum in culture media, and by the use of BMP4 in the first 2 days to promote neural crest specification. With this culture method, not only TuJ+ neurons were evident, but also GFAP+ and SOX10+ glial cells. The parallel inhibition of NOTCH‐signaling skews the differentiation toward neuronal lineages. On the other hand, a combination of EGF and FGF2 was used to induce the formation, and maintenance of neural crest cells that can be directed to their vagal fate using RA. , , Coculturing these neural crest cells with pluripotent stem cell‐derived intestinal organoids or gut explants, or implanting them into aneural gut tissue promotes their differentiation into enteric neurons and glia. , ,

DISCUSSION

This review provides an overview and comparison of different protocols to isolate and culture primary ENS cells from adult mice. Overall, the reviewed articles described similar approaches to obtain primary cultures from the ENS. However, because different outcome parameters were used, a direct comparison between protocols was difficult. Different sections of the mouse intestine are used for primary ENS cultures, with a preference for the small intestines, because of differences in muscle layer thickness, plexus density, and total number of ENS cells. It is important that dissection of the intestinal segments is done rapidly, as lengthy dissection times may reduce cell viability, due to degradation of the tissue in the presence of microbes and pancreatic enzymes, as the tissue is no longer protected against autodigestion by a functional intestinal barrier. , In general, two techniques are being used for the isolation of ENS cells. Technique I, the extraction of the LMMP from the unopened intestines (on a rod), is a faster procedure than technique II, extracting the LMMP after opening the intestines in a Sylgard dish, and technique I is therefore recommended. We found significant variation in the steps involving cell dissociation. Both a combination of digestive enzymes, serial enzymatic digestions, and enzyme‐free cell dissociation are being applied. Combinations of different enzymes allow for almost complete dissociation of the tissue, while preventing over‐digestion caused by long incubation times or high enzyme concentrations. Depending on the specific gut region that is targeted, incubation times have to be adapted. Also, adult tissue appears to be more challenging to dissociate due to increased complexity of the connective tissue and ECM with age. The use of collagenase for primary ENS cells is ideal due to the lack of internal collagen within the MP, allowing almost complete digestion of surrounding muscle‐ and connective tissue while keeping ENS structures mostly intact. , , Trypsin, the enzyme used in all reviewed protocols, has a very high digestive capacity, making incubation times of no longer than 10 minutes optimal. Regarding cellular adhesion, combinations of different coating substrates can enhance the complexity of the adherence matrix in in vitro systems, resulting in increased cell adhesion and survival. Wahba et al. (2015) investigated the differences of coating substrates on cell yield and density of cultures using poly‐D‐lysine, collagen, and Matrigel as single coating substrates, and poly‐D‐lysine‐Matrigel and collagen‐Matrigel double coating. Using DAPI to label individual cells, the authors observed the highest cell densities with a collagen‐Matrigel double coating. With respect to cell attachment, similar results were obtained for poly‐D‐lysine and Matrigel as single coatings. Adding poly‐D‐lysine or collagen to Matrigel coatings further improved cell attachement. Coating substrates may also influence cell differentiation in culture systems, more specifically, different compositions of the neural ECM can modulate the differentiation of ENS progenitors. A similar setup was used in the study by Verissimo et al. (2019). By using primary EGC cultures from adult murine intestines, the authors investigated the effects of laminin and other environmental cues on the neurogenic potential of EGCs. The study suggests that laminin possibly simulates the endogenous ECM microenvironment, resulting in significant inhibition of neuronal trans‐differentiation of EGCs in adult mice, compared to fibronectin‐coated plates. This emphasizes the importance of selecting an appropriate coating substrate for different adult ENS culture types. However, it is still not fully elucidated how EGCs activate their neurogenic potential in vitro and in vivo. Understanding the potential ability of these cells to give rise to neurons is challenging but would provide beneficial advancements on the role of ENS cells in regeneration and aging. As is the case for coating substrates, medium composition also influences (trans)differentiation and proliferation. The addition of specific growth factors, such as GDNF, can favor survival and proliferation of ENS (precursor) cells. One of the limitations of the current review was the lack of available data on the assessment of important cellular outcome parameters, such as cell viability and differentiation. The primary focus of the studies included was to characterize morphological and neurochemically defined subtypes of ENS cells in vitro by immunofluorescence assays, as well as imaging and electrophysiological studies to assess the functional properties of ENS populations. In order to assess and compare isolation protocols, it is important to validate if morphology, gene expression, and activity of ENS cells in vitro represent their characteristics in vivo. Potential markers to assess EGC cultures are S100β, Sox10, and GFAP, as they represent the main EGC phenotype in vivo. For ENS cultures, the presence and percentage of βIII‐tubulin+ cells in the culture should be reported, ideally with other neuronal subtype markers such as nNOS and ChAT. Depending on the research question, other validation methods can be added. This will improve the comparison between ENS culture protocols and the translatability of in vitro models. For example, Schneider et al. have validated purinergic receptor expression in their EGC cultures, similar to in vivo expression, and the protocols by Smith et al. and Wahba et al. have validated neuronal functionality in their ENS cultures. , Applications for primary ENS cultures include assessment of ENS response to different signals, such as GLP‐1, HIV protein, and gastrin, and studying effects of drugs and toxic agents on cell viability, proliferation, differentiation, and disease development. Co‐culture models with ENS cells and epithelium are also used to assess possible interactions and cell‐cell communication. , However, it is difficult to study the effects of one specific cell type in these primary cultures, as they are generally a mix of different cell types including enteric neurons and glia. Of note, even though neuronal markers, like βIII tubulin, are expressed after several days of culture, it is possible that these enteric neurons are derived from enteric glia cells or enteric glia‐like precursor cells that are present in adult mice , , , instead of being isolated enteric neurons. Although this review focuses on primary ENS cultures from adult mice, other available and robust methods for culturing ENS cells from distinct developmental stages should not be overlooked. A vast amount of primary ENS culture protocols that are currently published have focused on embryonic‐ or postnatal animals as a tissue source to obtain ENS cells. , , Although they are less favorable to study the physiology of mature enteric neurons and glia as they are stem cell‐derived cultures, the generation of 3D neurospheres is another possibility to study the ENS in vitro. They are mainly used to assess proliferation, multipotency, and stemness , , or are grown to serve as a source of donor cells in cell transplantation studies. , Recently, progress has been made in the generation of ENS cultures, thereby generating a possibility to study human ENS cells, enabling genetic editing and regenerative medicine purposes. In addition, intestinal organoids with a functional ENS can be generated to study cell‐cell communication in a complex and more holistic approach. , , Nonetheless, primary murine ENS cultures are still a valuable tool to understand fundamental aspects of ENS cell biology. The use of primary ENS cultures from mice as a model to investigate the role of the ENS in health and disease has been instrumental to advance our current understanding of ENS physiology and disease. Despite their limitations, primary cultures represent the physiological state of the cells better when compared to cell lines (generally derived from cancer cells), especially in the gut. ENS cultures allow studies on the molecular pathways that drive the physiological and pathological properties of these cells, which can be difficult to observe in vivo. Although the absence of microenvironmental cues acting in vivo significantly reduces the physiological relevance of in vitro studies, the improved accessibility to manipulate different components of the ENS outside the organism represents an important advantage for the understanding of specific questions related to ENS cell biology.

AUTHOR CONTRIBUTIONS

VM and WB were involved in manuscript concept. TTK was involved in initial manuscript draft and figure design. SS was involved in writing and shaping the manuscript. MI contributed to the section about human ENS cultures. VM, WB, and ACBF were involved in critical manuscript review. All authors approved the final version of the submitted review.
  98 in total

Review 1.  Optogenetic and chemogenetic techniques for neurogastroenterology.

Authors:  Werend Boesmans; Marlene M Hao; Pieter Vanden Berghe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-29       Impact factor: 46.802

2.  GDNF availability determines enteric neuron number by controlling precursor proliferation.

Authors:  Scott Gianino; John R Grider; Jennifer Cresswell; Hideki Enomoto; Robert O Heuckeroth
Journal:  Development       Date:  2003-05       Impact factor: 6.868

3.  Derivation of enteric neuron lineages from human pluripotent stem cells.

Authors:  Kevin Barber; Lorenz Studer; Faranak Fattahi
Journal:  Nat Protoc       Date:  2019-03-25       Impact factor: 13.491

Review 4.  Functions and imaging of mast cell and neural axis of the gut.

Authors:  Michael Schemann; Michael Camilleri
Journal:  Gastroenterology       Date:  2013-01-24       Impact factor: 22.682

5.  Mouse enteric neuronal cell culture.

Authors:  Yonggang Zhang; Wenhui Hu
Journal:  Methods Mol Biol       Date:  2013

Review 6.  The Enteric Nervous System for Epithelial Researchers: Basic Anatomy, Techniques, and Interactions With the Epithelium.

Authors:  Kathleen T Walsh; Anne E Zemper
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-05-18

Review 7.  Functional circuits and signal processing in the enteric nervous system.

Authors:  Candice Fung; Pieter Vanden Berghe
Journal:  Cell Mol Life Sci       Date:  2020-05-18       Impact factor: 9.261

8.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

9.  Caspase-11-mediated enteric neuronal pyroptosis underlies Western diet-induced colonic dysmotility.

Authors:  Lan Ye; Ge Li; Anna Goebel; Abhinav V Raju; Feng Kong; Yanfei Lv; Kailin Li; Yuanjun Zhu; Shreya Raja; Peijian He; Fang Li; Simon Musyoka Mwangi; Wenhui Hu; Shanthi Srinivasan
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

10.  Research applications of proteolytic enzymes in molecular biology.

Authors:  János András Mótyán; Ferenc Tóth; József Tőzsér
Journal:  Biomolecules       Date:  2013-11-08
View more
  1 in total

Review 1.  The gut brain in a dish: Murine primary enteric nervous system cell cultures.

Authors:  Simone L Schonkeren; Tara T Küthe; Musa Idris; Ana C Bon-Frauches; Werend Boesmans; Veerle Melotte
Journal:  Neurogastroenterol Motil       Date:  2021-07-08       Impact factor: 3.960

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.